Stock STIM NEURONETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Neuronetics, Inc.

Equities

STIM

US64131A1051

Real-time Estimate Cboe BZX
Other stock markets
 03:38:49 2024-04-29 pm EDT 		5-day change 1st Jan Change
3.52 USD +0.86% Intraday chart for Neuronetics, Inc. -5.75% +21.55%
Apr. 10 Neuronetics, Inc. Announces the Publication of Significant Clinical Findings in Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation CI
Mar. 28 Neuronetics, Inc. Announces John K. Bakewell, Joseph H. Capper and Dr. Wilfred E. Jaeger Not Stand for Reelection to the Board CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
AQ
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
GL
Neuronetics Reports Inducement Grant under Nasdaq Listing Rule 5635(4)
AQ
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
NeuroStar Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
AQ
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
GL
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
GL
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
AQ
Neuronetics : STIM Corporate Presentation March 2024
PU
Neuronetics: Q4 Earnings Snapshot
AQ
Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
AQ
Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call
AQ
Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
GL
Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
AQ
NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
GL
NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
AQ
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results
AQ
Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory
GL
Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory
AQ
NeuroStar TMS Receives Expanded Regulatory Approval in Japan
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. STIM Stock
  4. News Neuronetics, Inc.
  5. Press Releases